Skip to content

Innovation

A cancer treatment at the centre of an NHS controversy in 2014 causes fewer side effects in children than conventional radiotherapy, according to new research. The study, published in The Lancet Oncology, suggests proton beam therapy is as effective as other treatments. Researchers looked at 59 patients aged between three and 21 from 2003 to…

Read More

Monica Bertagnolli, WMIF co-chair, chief of the Division of Surgical Oncology at Brigham and Women’s Hospital and chair of the Alliance for Clinical Trials in Oncology, a nationwide effort to test new therapies, speaks on Barack Obama’s aspirational plan in his final State of the Union to “cure cancer.”

Read More

As a child growing up in the Sputnik era, Gary Ruvkun, PhD explored the night skies through the lens of a telescope and, as he learned more astronomy, realized with fascination that the universe has secret layers. “When you do visible astronomy, you see one set of stars. When you do X-ray as-tronomy, you see…

Read More

Initial results from the world’s largest ovarian cancer screening trial suggest that tracking levels of a cancer-associated protein over time may help reduce ovarian cancer deaths by as much as 20 percent. Results of the 14-year study, led by investigators at University College London (UCL), are being published online in The Lancet. The U.K. Collaborative…

Read More

Drones are increasingly being used in innovative ways—from responding to train derailments to documenting fall foliage. They’ve even made it into the fight against cancer—though on a much, much smaller scale. Dr. Wilfred Ngwa, a medical physicist in radiation oncology at Brigham and Women’s Hospital, is working to apply drone technology to cancer treatment. Ngwa…

Read More

Colon cancer is the third most common cancer diagnosed in men and women in the United States, according to American Cancer Society. Screenings are highly recommended for early detection, but many people dread these uncomfortable procedures which often involve inserting a tube in the rectum. New research published in JNCI: Journal of the National Cancer…

Read More

On Nov. 20, 2015, we lost one of our beloved warriors, Betty Lou Heath, but her story, unselfishly told to me by her beloved husband Kenneth, is a gift to all warriors that will live on. In 1997, Betty Lou Heath was working at Fairview Hospital in Great Barrington, Massachusetts. Talk about dedication: For 17…

Read More

Our family would like to express sincere thanks and gratitude to the Danvers High School Powder Puff Senior Girls Football Team for their generous contribution to the Adele McKinnon Fund for Breast Cancer Related Lymphedema Screening. The Danvers High senior girls opposed the Danvers High junior girls in the game played on Friday, Oct. 23.…

Read More

Mass General Brigham spin-off, Adheron, is acquired by Roche for $580 million. When pharmaceutical giant Roche announced plans to acquire Mass General Brigham spinoff Adheron Therapeutics in September, immunologist Michael Brenner, MD, couldn't help but recall the unlikely events that inspired the spinoff. The original spark that ignited Adheron's promising therapy for inflammatory and autoimmune…

Read More

A profile of Charles Serhan, PhD, DSc, a mastermind behind the inflammation pro-resolving therapies known as resolvins and the specialized pro-resolving mediators (SPM). Charles Serhan, PhD, DSc, a mastermind behind the inflammation pro-resolving therapies known as resolvins and the specialized pro-resolving mediators (SPM), is no stranger to the celebrity side of science. Coming of age…

Read More

A look at the promising oncology therapeutics under exploration by Mass General Brigham spin-off, Raze Therapeutics. A new approach to treating certain cancers may lie in an often-overlooked corner of amino acid metabolism, according to the science behind a new Mass General Brigham spinoff. Promising oncology therapeutics under exploration by Raze Therapeutics aim to dismantle…

Read More

A look into two of Innovation's Discovery Grant Profiles. Novel Treatments for Kidney Diseases Joseph Bonventre, MD, PhD BWH, RENAL Acute Kidney Injury is characterized by a rapid decline in kidney function and can be triggered by a number of insults. While AKI may resolve on its own or with care, the sequelae can include…

Read More